<DOC>
	<DOCNO>NCT00943969</DOCNO>
	<brief_summary>The bariatric surgery widely use treat obesity . Roux-en-Y gastric bypass one frequently surgical method perform combine restrictive malabsorptive procedure . Different data suggest surgery may modify drug absorption think would clinically relevant describe consequence gastric bypass drug systemic exposure obese patient , since data comparison pharmacokinetics ( PK ) drug surgery available help predict drug posology.The investigator decide study morphine lack information PK , pharmacodynamics ( PD ) et pharmacogenetics ( PG ) morphine obese subject , contrary anaesthetic drug . This drug narrow therapeutic range frequently prescribe obese patient .</brief_summary>
	<brief_title>Determinants Oral Morphine Answer Among Obese Patients Before After Gastric Bypass</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<criteria>Patients age 18 60 year old . Patients morbid obesity ( IMC &gt; 40 kg/m² ) severe obesity ( IMC=3540 kg/m² ) co morbidity ( sleep apnea syndrome hypertension steatosis hepatitis ) favourable decision multidisciplinary team gastric bypass . Patient agree go 3 time one day hospitalisation URT Lariboisière Hospital morphine PK/PD . Patient previous medical examination . Patient give wellinformed free consent information . diabetes concomitant sedative , antidepressive analgesic treatment drug unadvised morphine untreated sleep apnea syndrom , hypoxia ( PaO2 &lt; 70mmHg ) hypercapnia ( PaCO2 &gt; 45mmHg ) , anaemia &lt; 10g/dL , ASAT ALAT &gt; 3N</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>obesity</keyword>
	<keyword>gastric bypass</keyword>
	<keyword>morphine</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>absorption</keyword>
</DOC>